Table 1.

Demographic and Clinical Characteristics

	Patients (n = 110)
Demographics
Age (years)	36.6 ± 12.1
Gender (males %)	52.7 %
Education (years)	13.5 ± 2.9
Medication (OLZ eq mg)	15.2 ± 11.0
Duration of illness (years)	11.9 ± 11.6
Episodes (n)	7.0 ± 11.2
Assessments
PANSS-total	69.6 ± 20.7
Positive	14.6 ± 5.7
Negative	20.0 ± 7.6
TALD total	15.8 ± 9.0
Objective positive (relative)	0.3 ± 0.4
Objective negative (relative)	1.0 ± 0.9
Subjective positive (relative)	0.8 ± 0.9
Subjective negative (relative)	0.9 ± 0.6

Note: Values represent the mean ± SD.

Note: OLZ eq, olanzapine equivalent; PANSS, Positive And Negative Syndrome Scale; TALD, Thought and Language Disorder.